Knee osteoarthritis
Conditions
Interventions
foucusd extracorporeal shock wave therapy: 0.27 mJ/mm2, 2000 shots, 4 Hz, administered once weekly for 3 weeks to the site with bone marrow lesions. Physical therapy: Once weekly.
Physical therapy: On
Sponsors
Morinomiya University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients diagnosed with osteoarthritis of the knee, with a Visual Analogue Scale evaluation of 30 mm or more at the medial knee joint and bone marrow lesions at the medial tibiofemoral joint on MRI.
Exclusion criteria
Exclusion criteria: Grade IV in the Kellgren-Lawrence classification, history of knee trauma or neurological disease, bilateral symptomatic knee osteoarthritis, bone marrow lesions with osteonecrosis on MRI findings, systemic diseases such as rheumatoid arthritis, autoimmune diseases, tumors, and contraindications to ESWT systemic diseases such as rheumatoid arthritis, autoimmune diseases, and tumors, as well as those with contraindications to extracorporeal shock wave therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin concentration during walking (baseline, 3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Knee Injury and Osteoarthritis Outcome Score (baseline, 3 months), Bone marrow lesion volume (baseline, 3 months) | — |
Countries
Japan
Contacts
Public Contactshun okada
Morinomiya University of Medical Sciences research support center
Outcome results
None listed